The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Limanova O.A.

Ivanovo State Medical Academy, Ivanovo, Moscow Institute of Physics and Technology, Moscow

Gromov A.N.

Ivanovo State Medical Academy, Ivanovo, Moscow Institute of Physics and Technology, Moscow

Kerimkulova N.V.

Department of Obstetrics and Gynecology, Pediatric Faculty, Ivanovo State Medical Academy, Ministry of Health of Russia, Ivanovo, Russia

The comparative study of evidence based data concerning efficacy and safety of oral and transdermal estrogen replacement therapy in women of different age

Authors:

Gromova O.A., Torshin I.Iu., Limanova O.A., Gromov A.N., Kerimkulova N.V.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(6): 86‑96

Views: 22035

Downloaded: 593

Download PDF (RU)
Contact the author
Table of contents

THE COMPARATIVE STUDY OF EVIDENCE BASED DATA CONCERNING EFFICACY AND SAFETY OF ORAL AND TRANSDERMAL ESTROGEN REPLACEMENT THERAPY IN WOMEN OF DIFFERENT AGE
THE COMPARATIVE STUDY OF EVIDENCE BASED DATA CONCERNING EFFICACY AND SAFETY OF ORAL AND TRANSDERMAL ESTROGEN REPLACEMENT THERAPY IN WOMEN OF DIFFERENT AGE

To cite this article:

Gromova OA, Torshin IIu, Limanova OA, Gromov AN, Kerimkulova NV. The comparative study of evidence based data concerning efficacy and safety of oral and transdermal estrogen replacement therapy in women of different age. Russian Journal of Human Reproduction. 2013;(6):86‑96. (In Russ.)

Подписка 2025-2 (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Effe­ctiveness of spinal traction in dege­nerative spine diseases. (A lite­rature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(4):60-69
Role of estrogens in maintenance therapy of patients with pelvic organ prolapse. A systematic review. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):49-57
Dete­rmination of factors influencing the medi­cal checkups effe­ctiveness of adult popu­lation living in rural areas. Russian Journal of Preventive Medi­cine. 2024;(10):23-28
Open obse­rvational study with a retrospective analysis of the effi­cacy and tole­rability of aceclofenac in patients with acute non-specific low back pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):99-105
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Effi­cacy and safety of fonturacetam in asthenia: a systematic review and meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):69-79
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68

Authors:

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Limanova O.A.

Ivanovo State Medical Academy, Ivanovo, Moscow Institute of Physics and Technology, Moscow

Gromov A.N.

Ivanovo State Medical Academy, Ivanovo, Moscow Institute of Physics and Technology, Moscow

Kerimkulova N.V.

Department of Obstetrics and Gynecology, Pediatric Faculty, Ivanovo State Medical Academy, Ministry of Health of Russia, Ivanovo, Russia

List of references:

  1. Nussey S., Whitehead S. Endocrinology: an integrated approach. BIOS Scientific publishers 2001.
  2. Khadzhieva N.Kh., Kuznetsova I.V. Vozmozhnosti negormonal'nogo lecheniya stress-zavisimykh narushenii menstrual'nogo tsikla. Vserossiiskii nauchnyi forum "Mat' i ditya", 9-i: Materialy. M 2007; 550-551.
  3. Devis M. Dieta bioritmov: Nailuchshaya dieta, uchityvayushchaya estestvennyi gormononal'nyi tsikl zhenshchiny. M.: YaUZA; EKSMO-PRESS 1998.
  4. Lisitsyna E.Yu., Kalacheva A.G., Gogoleva I.V., Limanova O.A., Grishina T.R., Volkov A.Yu., Torshin I.Yu., Gromova O.A. Effektivnost' i bezopasnost' vitaminno-mineral'nogo preparata "Tsiklovita" v terapii sindroma predmenstrual'nogo napryazheniya. Ginekologiya 2012; 2: 21-27.
  5. Limanova O.A., Fedotova L.E., Lisitsyna E.Yu., Grishina T.R., Kalacheva A.G., Volkov A.Yu., Torshin I.Yu., Gromova O.A. Effektivnost' tsiklicheskoi mikronutrientnoi terapii pri narusheniyakh menstrual'noi funktsii i stanovlenii menarkhe. Ginekologiya 2012; 4: 72-79.
  6. Gromova O.A., Torshin I.Yu., Uvarova E.V. Tsiklicheskaya kationnaya terapiya dlya stimulyatsii menarkhe. Reproduktivnoe zdorov'e detei i podrostkov 2008; 11: 43.
  7. Samsioe G. Transdermal hormone therapy: gels and patches. Climacteric 2004; 7: 4: 347-356.
  8. Heiss G., Wallace R., Anderson G.L., Aragaki A., Beresford S.A., Brzyski R., Chlebowski R.T., Gass M., LaCroix A., Manson J.E., Prentice R.L., Rossouw J., Stefanick M.L. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008; 299: 9: 1036-1045.
  9. Ettinger B., Wang S.M., Leslie R.S., Patel B.V., Boulware M.J., Mann M.E., McBride M. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012; 19: 6: 610-615 doi.
  10. Goodman M.P. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt) 2012; 21: 2: 161-169 doi.
  11. Roach R.E., Lijfering W.M., Helmerhorst F.M., Cannegieter S.C., Rosendaal F.R., van Hylckama V.A. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. J Thrombol Haemost 2013; 11: 1: 124-131.
  12. Laliberte F., Dea K., Duh M.S., Kahler K.H., Rolli M., Lefebvre P. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause 2011; 18: 10: 1052-1059.
  13. Speroff L. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Climacteric 2010; 13: 5: 429-433.
  14. Renoux C., Dell'aniello S., Garbe E., Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010; 340: 2519.
  15. Wu O. Postmenopausal hormone replacement therapy and venous thromboembolism. Gend Med 2005; 2: Suppl A: S18-S27.
  16. Ho J.Y., Chen M.J., Sheu W.H., Yi Y.C., Tsai A.C., Guu H.F., Ho E.S. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women. Hum Reprod 2006; 21: 10: 2715-2720.
  17. Canonico M., Fournier A., Carcaillon L., Olie V., Plu-Bureau G., Oger E., Mesrine S., Boutron-Ruault M.C., Clavel-Chapelon F., Scarabin P.Y. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thrombol Vasc Biol 2010; 30: 2: 340-345.
  18. Shufelt C.L., Merz C.N., Prentice R.L., Pettinger M.B., Rossouw J.E., Aroda V.R., Kaunitz A.M., Lakshminarayan K., Martin L.W., Phillips L.S., Manson J.E. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause 2013.
  19. Sweetland S., Beral V., Balkwill A., Liu B., Benson V.S., Canonico M., Green J., Reeves G.K. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thrombol Haemost 2012.
  20. Lidegaard O., Lokkegaard E., Jensen A., Skovlund C.W., Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012; 366: 24: 2257-2266.
  21. Racine A., Bijon A., Fournier A., Mesrine S., Clavel-Chapelon F., Carbonnel F., Boutron-Ruault M.C. Menopausal hormone therapy and risk of cholecystectomy: a prospective study based on the French E3N cohort. CMAJ 2013; 185: 7: 555-561.
  22. Liu B., Beral V., Balkwill A., Green J., Sweetland S., Reeves G. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. BMJ 2008; 337: a386.
  23. Shakir Y.A., Samsioe G., Nerbrand C., Lidfeldt J. Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women's Health in the Lund Area study. Menopause 2004; 11: 5: 549-555.
  24. Salpeter S.R., Walsh J.M., Ormiston T.M., Greyber E., Buckley N.S., Salpeter E.E. Metaanalysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metabol 2006; 8: 5: 538-554.
  25. Torres-Santiago L., Mericq V., Taboada M., Unanue N., Klein K.O., Singh R., Hossain J., Santen R.J., Ross J.L., Mauras N. Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): a randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metabol 2013; 98: 7: 2716-2724.
  26. Mah P.M., Webster J., Jonsson P., Feldt-Rasmussen U., Koltowska-Haggstrom M., Ross R.J. Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metabol 2005; 90: 11: 59-64.
  27. Opatrny L., Dell'Aniello S., Assouline S., Suissa S. Hormone replacement therapy use and variations in the risk of breast cancer. BJOG 2008; 115: 2: 169-175; discussion.
  28. Corrao G., Zambon A., Conti V., Nicotra F., La Vecchia C., Fornari C., Cesana G., Contiero P., Tagliabue G., Nappi R.E., Merlino L. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol 2008; 19: 1: 150-155.
  29. Takeda T., Wong T.F., Kitamura M., Yaegashi N. Estrogen formulations and beauty care practices in Japanese women. Int J Womens Health 2012; 4: 19-24.
  30. Pratapkumar A.V. A comparison of transdermal and oral HRT for menopausal symptom control. Int J Fertil Womens Med 2006; 51: 2: 64-69.
  31. Jarvinen A., Nykanen S., Paasiniemi L. Absorption and bioavailability of oestradiol from a gel, a patch and a tablet. Maturitas 1999; 32: 2: 103-113.
  32. Travassos de Figueiredo Alves, Amelia Sobreira Gomes M., Clapauch R. Comparison of gel and patch estradiol replacement in Brazil, a tropical country. Maturitas 2000; 36: 1: 69-74.
  33. Hirvonen E., Cacciatore B., Wahlstrom T., Rita H., Wilen-Rosenqvist G. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch. Br J Obstet Gynaecol 1997; 104: Suppl: 26-31.
  34. Archer D.F., Pickar J.H., MacAllister D.C., Warren M.P. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women. Menopause 2012; 19: 6: 622-629.
  35. Yang T.S., Chen Y.J., Liang W.H., Chang C.Y., Tai L.C., Chang S.P., Ng H.T. A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study. J Chin Med Ass 2007; 70: 5: 200-206.
  36. Archer D.F. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women. Menopause 2003; 10: 6: 516-521.
  37. Hedrick R.E., Ackerman R.T., Koltun W.D., Halvorsen M.B., Lambrecht L.J. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Menopause 2009; 16: 1: 132-140.
  38. Mizunuma H. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms. Climacteric 2011; 14: 5: 581-589.
  39. Jarvinen A., Granander M., Nykanen S., Laine T., Geurts P., Viitanen A. Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing. Br J Obstet Gynaecol 1997; 104: Suppl: 14-18.
  40. Registr lekarstvennykh sredstv RF, 2013, www.rlsnet.ru

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.